Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medtronic plc Director's Dealing 2022

Dec 9, 2022

29841_dirs_2022-12-09_3b5cb682-51f2-4787-a2ea-0cc3e9fd9838.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2022-12-07

Reporting Person: Salmon Sean (EVP & President Cardiovascular)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-12-07 Ordinary Shares F 300 $79.04 Disposed 36088 Direct

Footnotes

F1: This balance increased by 174 shares due to exempt acquisitions through dividend reinvestment.

F2: The reported transaction involved the withholding of 300 shares of stock issuable upon the early vesting of an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible.